Capstone Investment Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Capstone Investment Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-30,419	Closed	-$2.83M	–	2239
2021 Q4	$2.83M	Buy	+30,419	New	+$2M	﹤0.01%	1007

Capstone Investment Advisors's ARNA Position: Q1 2022 in Review

Capstone Investment Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 30,419 shares — an estimated $2.83M sold.

Capstone Investment Advisors first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $2.83M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Capstone Investment Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Capstone Investment Advisors sold 30,419 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $2.83M.
Capstone Investment Advisors first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
Capstone Investment Advisors's Arena Pharmaceuticals Inc position peaked at $2.83M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Capstone Investment Advisors's 13F filing for Q1 2022, filed 13 May 2022.